Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Bladder Cancer

  Free Subscription


1 Acta Cytol
1 Anesth Analg
1 Ann R Coll Surg Engl
1 Biomed Res Int
1 Bull Cancer
1 Cancer Discov
1 Cancer Med
1 Cancer Radiother
1 Cancer Treat Rev
1 Clin Cancer Res
1 Clin Genitourin Cancer
1 Clin Oncol (R Coll Radiol)
1 Diagn Cytopathol
1 Expert Opin Drug Metab Toxicol
1 Future Oncol
1 Gulf J Oncolog
1 Hum Exp Toxicol
1 Int J Urol
1 J Magn Reson Imaging
1 J Urol
2 Jpn J Clin Oncol
2 Medicine (Baltimore)
1 Nanomedicine (Lond)
2 Oncoimmunology
1 Oncol Rep
3 Oncotarget
2 PLoS One
2 Sci Rep
1 Urol Oncol
1 Urology
1 Virchows Arch

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Acta Cytol

  1. GRANADOS R, Duarte JA, Corrales T, Camarmo E, et al
    Applying the Paris System for Reporting Urine Cytology Increases the Rate of Atypical Urothelial Cells in Benign Cases: A Need for Patient Management Recommendations.
    Acta Cytol. 2017;61:71-76.
    PubMed     Text format     Abstract available

    Anesth Analg

  2. JAEGER MT, Siemens DR, Wei X, Peng P, et al
    Association Between Anesthesiology Volumes and Early and Late Outcomes After Cystectomy for Bladder Cancer: A Population-Based Study.
    Anesth Analg. 2017 Feb 15. doi: 10.1213/ANE.0000000000001781.
    PubMed     Text format     Abstract available

    Ann R Coll Surg Engl

  3. MANLEY KV, Hubbard R, Swallow D, Finch W, et al
    Risk factors for development of primary bladder squamous cell carcinoma.
    Ann R Coll Surg Engl. 2017;99:155-160.
    PubMed     Text format     Abstract available

    Biomed Res Int

  4. SU X, Fang D, Li X, Xiong G, et al
    The Influence of Tumor Size on Oncologic Outcomes for Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy.
    Biomed Res Int. 2016;2016:4368943.
    PubMed     Text format     Abstract available

    Bull Cancer

  5. GRAPIN-DAGORNO C, Peycelon M, Philippe-Chomette P, Berrebi D, et al
    [Urothelial tumors in children].
    Bull Cancer. 2017;104:195-201.
    PubMed     Text format     Abstract available

    Cancer Discov

  6. Nivolumab Gets FDA Nod for Bladder Cancer.
    Cancer Discov. 2017 Feb 9. doi: 10.1158/2159-8290.CD-NB2017.
    PubMed     Text format     Abstract available

    Cancer Med

  7. WANG CY, Hua R, Liu L, Zhan X, et al
    Immunotherapy against metastatic bladder cancer by combined administration of granulocyte macrophage-colony stimulating factor and interleukin-2 surface modified MB49 bladder cancer stem cells vaccine.
    Cancer Med. 2017 Feb 16. doi: 10.1002/cam4.1023.
    PubMed     Text format     Abstract available

    Cancer Radiother

  8. SARGOS P, Larre S, Chapet O, Latorzeff I, et al
    [Adjuvant radiotherapy for bladder cancer in patients with risk of locoregional recurrence: Who, what and how?]
    Cancer Radiother. 2017 Feb 7. pii: S1278-3218(17)30004.
    PubMed     Text format     Abstract available

    Cancer Treat Rev

  9. SOLINAS C, Chanza NM, Awada A, Scartozzi M, et al
    The immune infiltrate in prostate, bladder and testicular tumors: An old friend for new challenges.
    Cancer Treat Rev. 2017;53:138-145.
    PubMed     Text format     Abstract available

    Clin Cancer Res

  10. SIN ML, Mach KE, Sinha R, Wu F, et al
    Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics.
    Clin Cancer Res. 2017 Feb 13. pii: clincanres.2610.2016.
    PubMed     Text format     Abstract available

    Clin Genitourin Cancer

  11. BUSETTO GM, Ferro M, Del Giudice F, Antonini G, et al
    The Prognostic Role of Circulating Tumor Cells (CTC) in High-risk Non-muscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2017 Jan 18. pii: S1558-7673(17)30011.
    PubMed     Text format     Abstract available

    Clin Oncol (R Coll Radiol)

  12. TRAINOR S, Choudhury A, Huddart R, Kiltie AE, et al
    The National Institute for Health and Care Excellence (NICE) Guidance on Bladder Cancer; a Step in the Right Direction?
    Clin Oncol (R Coll Radiol). 2017 Feb 9. pii: S0936-6555(17)30068.
    PubMed     Text format    

    Diagn Cytopathol

  13. SHANMUGAM V, Geraghty B, DeSimone R, Hoda RS, et al
    Diagnostic value of positive urinary cytology in the detection of recurrent urothelial carcinoma: 10-Year Experience at the Papanicolaou Cytology Laboratory.
    Diagn Cytopathol. 2016 Sep 26. doi: 10.1002/dc.23598.
    PubMed     Text format     Abstract available

    Expert Opin Drug Metab Toxicol

  14. PATEL R, Bock M, Polotti CF, Elsamra S, et al
    Pharmacokinetic drug evaluation of atezolizumab for the treatment of locally advanced or metastatic urothelial carcinoma.
    Expert Opin Drug Metab Toxicol. 2017;13:225-232.
    PubMed     Text format     Abstract available

    Future Oncol

  15. AOUN F, El Rassy E, Peltier A
    Bladder cancer immunotherapy: swinging for the fences.
    Future Oncol. 2017 Feb 10. doi: 10.2217/fon-2017-0013.
    PubMed     Text format    

    Gulf J Oncolog

  16. GUPTA S, De S, Leekha N, Sahay SC, et al
    Chemoradiation for organ preservation in the treatment of muscle invasive bladder cancer: Our Institutional Experience.
    Gulf J Oncolog. 2016;1:55-60.
    PubMed     Text format     Abstract available

    Hum Exp Toxicol

  17. PRABHU B, Balakrishnan D, Sundaresan S
    Antiproliferative and anti-inflammatory properties of diindolylmethane and lupeol against N-butyl-N-(4-hydroxybutyl) nitrosamine induced bladder carcinogenesis in experimental rats.
    Hum Exp Toxicol. 2016;35:685-92.
    PubMed     Text format     Abstract available

    Int J Urol

  18. INOUE K
    5-Aminolevulinic acid-mediated photodynamic therapy for bladder cancer.
    Int J Urol. 2017;24:97-101.
    PubMed     Text format     Abstract available

    J Magn Reson Imaging

  19. ZHANG X, Xu X, Tian Q, Li B, et al
    Radiomics assessment of bladder cancer grade using texture features from diffusion-weighted imaging.
    J Magn Reson Imaging. 2017 Feb 15. doi: 10.1002/jmri.25669.
    PubMed     Text format     Abstract available

    J Urol

    Re: Comparative Effectiveness of Fluorescent versus White Light Cystoscopy for Initial Diagnosis or Surveillance of Bladder Cancer on Clinical Outcomes: Systematic Review and Meta-Analysis: R. Chou, S. Selph, D. I. Buckley, R. Fu, J. C. Griffin, S. Gr
    J Urol. 2017 Feb 6. pii: S0022-5347(16)32070-5. doi: 10.1016/j.juro.2016.
    PubMed     Text format    

    Jpn J Clin Oncol

  21. UKAI R, Hashimoto K, Nakayama H, Iwamoto T, et al
    Lymphovascular invasion predicts poor prognosis in high-grade pT1 bladder cancer patients who underwent transurethral resection in one piece.
    Jpn J Clin Oncol. 2017 Feb 10:1-6. doi: 10.1093.
    PubMed     Text format    

  22. MATSUDA T, Okuyama A
    Incidence rate for bladder cancer in Japanese in Japan and in the United States from the Cancer Incidence in Five Continents.
    Jpn J Clin Oncol. 2017 Feb 16:1-2. doi: 10.1093.
    PubMed     Text format    

    Medicine (Baltimore)

  23. SHAO YH, Kao CC, Tang SH, Cha TL, et al
    Unusual presentation of direct intraperitoneal metastases complicated with massive ascites from plasmacytoid variant of bladder cancer and adenocarcinoma of colon: A case report and literature review.
    Medicine (Baltimore). 2017;96:e5816.
    PubMed     Text format     Abstract available

  24. ZHAN L, Zhang B, Tan Y, Yang C, et al
    Quantitative assessment of the relationship between RASSF1A gene promoter methylation and bladder cancer (PRISMA).
    Medicine (Baltimore). 2017;96:e6097.
    PubMed     Text format     Abstract available

    Nanomedicine (Lond)

  25. REZAEI G, Habibi-Anbouhi M, Mahmoudi M, Azadmanesh K, et al
    Development of anti-CD47 single-chain variable fragment targeted magnetic nanoparticles for treatment of human bladder cancer.
    Nanomedicine (Lond). 2017 Feb 10. doi: 10.2217/nnm-2016-0302.
    PubMed     Text format     Abstract available


  26. SMITH SG, Baltz JL, Koppolu BP, Ravindranathan S, et al
    Immunological mechanisms of intravesical chitosan/interleukin-12 immunotherapy against murine bladder cancer.
    Oncoimmunology. 2016;6:e1259050.
    PubMed     Text format     Abstract available

  27. DOMINGOS-PEREIRA S, Cesson V, Chevalier MF, Derre L, et al
    Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer.
    Oncoimmunology. 2016;6:e1265720.
    PubMed     Text format     Abstract available

    Oncol Rep

  28. LI W, Liu J, Zou D, Cai X, et al
    Exploration of bladder cancer molecular mechanisms based on miRNA-mRNA regulatory network.
    Oncol Rep. 2017;37:1461-1468.
    PubMed     Text format     Abstract available


  29. DONG F, Xu T, Shen Y, Zhong S, et al
    Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedure.
    Oncotarget. 2017 Feb 7. doi: 10.18632/oncotarget.15173.
    PubMed     Text format     Abstract available

  30. PEI Z, Du X, Song Y, Fan L, et al
    Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/beta-catenin signaling pathway.
    Oncotarget. 2017 Feb 9. doi: 10.18632/oncotarget.15210.
    PubMed     Text format     Abstract available

  31. FU D, Li P, Cheng W, Tian F, et al
    Impact of vascular endothelial growth factor gene-gene and gene-smoking interaction and haplotype combination on bladder cancer risk in Chinese population.
    Oncotarget. 2017 Feb 11. doi: 10.18632/oncotarget.15287.
    PubMed     Text format     Abstract available

    PLoS One

  32. XIONG Y, Li J, Ma S, Ge J, et al
    A meta-analysis of narrow band imaging for the diagnosis and therapeutic outcome of non-muscle invasive bladder cancer.
    PLoS One. 2017;12:e0170819.
    PubMed     Text format     Abstract available

  33. SHIN SS, Song JH, Hwang B, Noh DH, et al
    HSPA6 augments garlic extract-induced inhibition of proliferation, migration, and invasion of bladder cancer EJ cells; Implication for cell cycle dysregulation, signaling pathway alteration, and transcription factor-associated MMP-9 regulation.
    PLoS One. 2017;12:e0171860.
    PubMed     Text format     Abstract available

    Sci Rep

  34. BETTIGA A, Aureli M, Colciago G, Murdica V, et al
    Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism.
    Sci Rep. 2017;7:42157.
    PubMed     Text format     Abstract available

  35. KISS B, Wyatt AW, Douglas J, Skuginna V, et al
    Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapy.
    Sci Rep. 2017;7:42713.
    PubMed     Text format     Abstract available

    Urol Oncol

  36. RICHARD PO, Ahmad AE, Bashir S, Hamilton RJ, et al
    Effect of statins as a secondary chemopreventive agent among individuals with non-muscle-invasive bladder cancer: A population-based analysis.
    Urol Oncol. 2017 Feb 9. pii: S1078-1439(16)30417.
    PubMed     Text format     Abstract available


  37. PAK JS, Lee JJ, Bilal K, Finkelstein M, et al
    Utilization Trends and Short-Term Outcomes of Robotic Versus Open Radical Cystectomy for Bladder Cancer.
    Urology. 2017 Feb 8. pii: S0090-4295(17)30124.
    PubMed     Text format     Abstract available

    Virchows Arch

  38. BREYER J, Wirtz RM, Laible M, Schlombs K, et al
    ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC).
    Virchows Arch. 2016;469:547-552.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.